Table 1.
Patient characteristics and treatment disposition
| Variable | Nivo+CT (n = 22) | Ipi+Nivo+CT (n = 22) | |
|---|---|---|---|
| Age—median (range), years | 69.5 (45.6–79.3) | 63.1 (39.4–77.5) | |
| Age—number (%) | <65 years | 10 (45) | 13 (59) |
| >65 years | 12 (55) | 9 (41) | |
| Sex—number (%) | Female | 12 (55) | 7 (32) |
| Male | 10 (45) | 15 (68) | |
| Race—number (%) | Asian NOS | 3 (14) | 1 (5) |
| Black | 0 (0) | 3 (14) | |
| White | 19 (86) | 18 (82) | |
| Smoking status—number (%) | Never smoker | 5 (23) | 5 (23) |
| Former smoker/current smoker | 17 (77) | 17 (77) | |
| Stage—number (%) | Stage IB (≥4 cm) or II | 11 (50) | 9 (41) |
| Stage IIIA | 11 (50) | 13 (59) | |
| Histology—number (%) | Non-squamous | 17 (77) | 17 (77) |
| Squamous | 5 (23) | 5 (23) | |
| ECOG PS—number (%) | 0 | 10 (45) | 16 (73) |
| 1 | 12 (55) | 6 (27) | |
| Mediastinal staging—number (%) | EBUS | 21 (95) | 22 (100) |
| Mediastinoscopy | 1 (5) | 0 (0) |
EBUS, endobronchial ultrasound; NOS, not otherwise specified. Non-squamous includes adenocarcinoma, carcinoma with neuroendocrine features, NOS NSCLC, sarcomatoid carcinoma and large cell carcinoma.